Figure 3 and Supplementary Table 1 demonstrate that TLR1-10 combined in the analysis are highly significantly associated with improved survival in both NSCLC (HR = 0.54, P = 2.7 × 10−10) and ADC patients (HR = 0.38, P = 3.0x 10−9). The gene discussed is TLR1; the disease is non-small cell lung carcinoma.